Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment.

obviously it’s new and recent research, but holy heck

  • Pennomi@lemmy.worldEnglish
    9·
    6 days ago

    accounting for 15% of all cancer diagnoses in the US

    Wow, that’s a significant portion of cancer this would be effective against. Assuming it still works for humans.